Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 49.16M P/E - EPS this Y 26.80% Ern Qtrly Grth -
Income -63.03M Forward P/E -0.80 EPS next Y 20.10% 50D Avg Chg -13.00%
Sales 11.32M PEG - EPS past 5Y - 200D Avg Chg -11.00%
Dividend N/A Price/Book 0.31 EPS next 5Y - 52W High Chg -51.00%
Recommedations 3.00 Quick Ratio 5.52 Shares Outstanding 38.13M 52W Low Chg 10.00%
Insider Own 3.47% ROA -26.81% Shares Float 21.43M Beta 0.93
Inst Own 64.28% ROE -48.14% Shares Shorted/Prior 1.85M/1.98M Price 1.30
Gross Margin - Profit Margin - Avg. Volume 144,527 Target Price 1.25
Oper. Margin -324.08% Earnings Date Aug 5 Volume 28,668 Change -1.52%
About Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Bolt Biotherapeutics, Inc. News
05/24/24 The Analyst Anxiety Index: 3 Stocks to Avoid as Uncertainty Grows
05/15/24 Bolt Biotherapeutics Inc (BOLT) (Q1 2024) Earnings Call Transcript Highlights: Strategic Shifts ...
05/15/24 Bolt Biotherapeutics to lay off staff, abandon lead ADC candidate
05/14/24 Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team
04/29/24 Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
03/21/24 Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
02/27/24 Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
12/21/23 Pacira Appoints Frank D. Lee as Chief Executive Officer
12/05/23 Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertuยฎ
11/20/23 Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Invest In Growth?
11/09/23 Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
11/07/23 Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference
10/24/23 10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
10/23/23 Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress
10/18/23 Bolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancerโ€™s 2023 Annual Meeting
10/17/23 Bolt Biotherapeutics Announces First Patient Dosed in Phase 1/2 Study of BDC-3042 in Patients with Advanced Cancers
10/16/23 Bolt Biotherapeutics to Present New Clinical Data from Completed Phase 1/2 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Solid Tumors at the ESMO Congress 2023
09/28/23 Bolt Biotherapeutics Receives Orphan Drug Designation for BDC-1001 for Treatment of Gastric Cancers
09/12/23 Bolt Biotherapeutics Announces Issuance of U.S. Patent Covering Dectin-2-Targeting Agonist Antibodies, Including BDC-3042
09/05/23 Bolt Biotherapeutics to Participate in September Investor Conferences
BOLT Chatroom

User Image Big_Baggies Posted - 10 hours ago

$BOLT this junk is still just 2 cents above its low?? Just a matter of time til it gets flushed like a turd

User Image newsfile_corp Posted - 15 hours ago

https://nfne.ws/217478 $BOLT @faruqilaw #Banking #FinancialServices #NASDAQ #Investing

User Image newsfile_corp Posted - 1 day ago

https://nfne.ws/217470 $BOLT @rosen_firm #Banking #FinancialServices #NASDAQ #Investing

User Image newsfile_corp Posted - 1 day ago

https://nfne.ws/217341 $BOLT @faruqilaw #Banking #FinancialServices #NASDAQ #Investing

User Image newsfile_corp Posted - 3 days ago

https://nfne.ws/217250 $BOLT @rosen_firm #Banking #FinancialServices #NASDAQ #Investing

User Image newsfile_corp Posted - 3 days ago

https://nfne.ws/217141 $BOLT @faruqilaw #Banking #FinancialServices #NASDAQ #Investing

User Image newsfile_corp Posted - 4 days ago

https://nfne.ws/217216 $BOLT @rosen_firm #Banking #FinancialServices #NASDAQ #Investing

User Image 11thestate Posted - 5 days ago

Secure Your Bolt Biotherapeutics Payout! $BOLT stockholder filed a claim against Bolt Biotherapeutics for overstating its lead drug's potential, which risked leadership changes and job cuts. You can join this case to be notified about potential recovery: https://11thestate.com/cases/bolt-investor-suit

User Image 11thestate Posted - 6 days ago

$BOLT stockholder filed a claim against Bolt Biotherapeutics for overstating its lead drug's potential, which risked leadership changes and job cuts. You can join this case to be notified about potential recovery: https://11thestate.com/cases/bolt-investor-suit

User Image BiotechSwingz Posted - 6 days ago

$BOLT loading more here. bottomed out.

User Image newsfile_corp Posted - 1 week ago

https://nfne.ws/216879 $BOLT @faruqilaw #Banking #FinancialServices #NASDAQ #Investing

User Image newsfile_corp Posted - 1 week ago

https://nfne.ws/216899 $BOLT @rosen_firm #Banking #FinancialServices #NASDAQ #Investing

User Image DipBuyInvester Posted - 1 week ago

$BOLT ๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€

User Image newsfile_corp Posted - 1 week ago

https://nfne.ws/216707 $BOLT @faruqilaw #Banking #FinancialServices #NASDAQ #Investing

User Image DipBuyInvester Posted - 1 week ago

$BOLT can explode any time !!๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€

User Image newsfile_corp Posted - 1 week ago

https://nfne.ws/216705 $BOLT @rosen_firm #Banking #FinancialServices #NASDAQ #Investing

User Image DipBuyInvester Posted - 1 week ago

$BOLT Shorts tried a lot to get it down. There is no way!! Squeezing.๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€๐Ÿš€

User Image newsfile_corp Posted - 1 week ago

https://nfne.ws/216638 $BOLT #Banking #FinancialServices #NASDAQ #Investing

User Image PCtrader20 Posted - 1 week ago

$BOLT large ask order in PM

User Image DipBuyInvester Posted - 1 week ago

$BOLT This is a 10X play!!

User Image newsfile_corp Posted - 1 week ago

https://nfne.ws/216444 $BOLT @rosen_firm #Banking #FinancialServices #NASDAQ #Investing

User Image newsfile_corp Posted - 1 week ago

https://nfne.ws/216435 $BOLT @rosen_firm #Banking #FinancialServices #NASDAQ #Investing

User Image newsfile_corp Posted - 1 week ago

https://nfne.ws/216320 $BOLT @faruqilaw #Banking #FinancialServices #NASDAQ #Investing

User Image mastertrader7 Posted - 1 week ago

Yamaha $BOLT

User Image DipBuyInvester Posted - 1 week ago

$BOLT 10x potential !!

User Image PCtrader20 Posted - 1 week ago

$BOLT itโ€™s time for this to move after 2 months of quiet time! Should pass over $1 soon!

User Image BiotechSwingz Posted - 1 week ago

$BOLT over 1$ in no time. Tang big here. Netcash 2$, burn low, no warrants

User Image newsfile_corp Posted - 1 week ago

https://nfne.ws/216255 $BOLT @rosen_firm #Banking #FinancialServices #NASDAQ #Investing

User Image 11thestate Posted - 1 week ago

$BOLT stockholder filed a claim against BoltBiotherapeutics for overstating its lead drug's potential, which risked leadership changes and job cuts. You can join this case to be notified about potential recovery: https://11thestate.com/cases/bolt-investor-suit

User Image Bobby_J_Bomb Posted - 2 weeks ago

$BOLT spreading it out and taking a starter here.

Analyst Ratings
Leerink Partners Market Perform May 15, 24
Jones Trading Hold May 15, 24
HC Wainwright & Co. Neutral May 15, 24
Guggenheim Neutral May 15, 24
Stifel Hold May 15, 24
HC Wainwright & Co. Buy Mar 22, 24
HC Wainwright & Co. Buy Aug 8, 23
HC Wainwright & Co. Buy Aug 3, 23
HC Wainwright & Co. Buy Jun 5, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Quinn William P. Chief Financial Offi.. Chief Financial Officer Dec 12 Buy 0.97 11,829 11,474 36,272 12/13/23
ENGLEMAN EDGAR Director Director Nov 29 Sell 0.88 148,884 131,018 251,522 12/01/23
ENGLEMAN EDGAR Director Director Nov 21 Sell 0.9 1,943 1,749 269,587 11/22/23
Vivo Capital VIII, LLC 10% Owner 10% Owner Nov 21 Sell 0.9 3,400 3,060 111,662 11/22/23
ENGLEMAN EDGAR Director Director Nov 16 Sell 0.94 49,173 46,223 269,823 11/20/23
Vivo Capital VIII, LLC 10% Owner 10% Owner Nov 16 Sell 0.94 86,054 80,891 113,119 11/20/23
Novo Holdings A/S 10% Owner 10% Owner Jul 13 Sell 2.00 800,000 1,600,000 3,703,991 07/15/22
Perez Edith A. Chief Medical Office.. Chief Medical Officer Dec 22 Option 2.8 35,714 99,999 37,042 02/01/22
Perez Edith A. Chief Medical Office.. Chief Medical Officer Dec 22 Buy 10.65 1,328 14,143 1,328 02/01/22